A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new ...

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. A new treatment ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...

Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...